M&A

Novartis further entrenches into radiopharma with $1B Mariana buy
Fierce Biotech
Thu, 05/2/24 - 11:41 am
Novartis
M&A
Mariana Oncology
radiopharmaceuticals
Quest Finds its Path to AI in Cancer Diagnostics Through M&A
Medical Devices and Diagnostics Industry
Wed, 05/1/24 - 11:13 pm
Medtech
Quest Diagnostics
diagnostics
M&A
PathAI Diagnostics
R&D
artificial intelligence
Sweet Harmony: Neuro biotech buys Epygenix and its epilepsy meds for $35M upfront
Fierce Biotech
Tue, 04/30/24 - 06:36 pm
Harmony Biosciencws
Epygenix
M&A
epilepsy
M&A rumor mill is buzzing as Publicis pulls ahead of agency pack
Medical Marketing and Media
Tue, 04/30/24 - 06:28 pm
pharma marketing
M&A
Publicis
Ono swoops on Deciphera in $2.4 billion takeover
Pharmaphorum
Mon, 04/29/24 - 09:54 am
Ono Pharma
Deciphera Pharma
M&A
Labcorp to acquire Invitae’s assets for $239M
Medtech Dive
Thu, 04/25/24 - 05:52 pm
LabCorp
M&A
Invitae
diagnostics
Medtech
Emergence of ADCs as the “hot, new technology”
Pharmaphorum
Thu, 04/25/24 - 11:39 am
antibody-drug conjugate
Immunogen
AbbVie
Seagen
Pfizer
cancer
M&A
Biogen: Don’t expect any big acquisitions this year
BioPharma Dive
Wed, 04/24/24 - 09:31 pm
Biogen
Pharma CEOs
Chris Viehbacher
M&A
Incyte Inks $750M Deal to Buy Escient and Skin Disease Drug Candidates
BioSpace
Tue, 04/23/24 - 09:46 pm
Incyte
M&A
Escient Pharma
atopic dermatitis
Biopharma M&A more than doubled in the first quarter compared to the year prior: report
Fierce Biotech
Thu, 04/18/24 - 11:11 am
M&A
biotech
AstraZeneca
Merck
Gracell
Harpoon Therapeutics
‘We think in decades’: J&J’s $30B spending spree may not be over
Medtech Dive
Tue, 04/16/24 - 10:07 pm
JNJ
Medtech
M&A
Abiomed
Laminar
Shockwave Medical
A two-decade bet on Seagen pays off
Stat
Mon, 04/15/24 - 11:03 am
Pfizer
Seagen
M&A
Merck Paid $208 Million to Stop Its Drugs From Working
Motley Fool
Sun, 04/14/24 - 01:27 pm
Merck
M&A
Abceutics
antibody-drug conjugate
Novartis may have bought MorphoSys, but it really only had eyes for BET inhibitor pelabresib: filing
Fierce Biotech
Fri, 04/12/24 - 11:23 am
Novartis
MorphoSys
pelabresib
myelofibrosis
M&A
BET inhibitor
EU approves Illumina's plan to divest cancer test maker Grail
Reuters
Fri, 04/12/24 - 11:08 am
Europe
Illumina
Grail
M&A
diagnostics
Medtech
What about the company Vertex didn’t buy?
Stat
Fri, 04/12/24 - 11:05 am
Vertex Pharmaceuticals
M&A
Alpine Immune Sciences
Vera Therapeutics
IgA nephropathy
Novartis begins tender offer for cancer-focused MorphoSys
Reuters
Thu, 04/11/24 - 11:54 am
Novartis
M&A
cancer
MorphoSys
Pfizer settles 12-year-old lawsuit in alleged pay-for-delay scheme for $39M
Fierce Pharma
Thu, 04/11/24 - 11:31 am
Pfizer
legal
Wyeth
M&A
pay-for-delay
antitrust
Vertex to buy kidney disease drugmaker Alpine for $4.9B
BioPharma Dive
Wed, 04/10/24 - 06:05 pm
Vertex Pharmaceuticals
M&A
Alpine Immune Sciences
IgA nephropathy
7 Billion-Dollar Oncology M&As from Q1
BioSpace
Wed, 04/10/24 - 11:24 am
oncology
M&A
AbbVie
Immunogen
Bristol Myers Squibb
Mirati Therapeutics
RayzeBio
Novartis
MorphoSys
AstraZeneca
Fusion Pharmaceuticals
JNJ
Ambrx
Gracell

Pages